FRT
39
-7
VIX
25
-8
GILD
47
-3
BWA
40
-4
DVA
72
-3
GPC
43
5
UHS
58
-2
AME
60
-3
ITW
58
-4
PM
62
2
KLAC
65
4
AAL
32
3
SYF
88
-2
PX
59
-3
PAYX
54
-2
AIG
51
-3
INTC
45
4
NTRS
37
-7
PEG
44
-2
THC
67
-3
FRT
39
-7
VIX
25
-8
GILD
47
-3
BWA
40
-4
DVA
72
-3
GPC
43
5
UHS
58
-2
AME
60
-3
ITW
58
-4
PM
62
2
KLAC
65
4
AAL
32
3
SYF
88
-2
PX
59
-3
PAYX
54
-2
AIG
51
-3
INTC
45
4
NTRS
37
-7
PEG
44
-2
THC
67
-3
Financhill
Back

Brookline Bancorp Vs. Keros Therapeutics Industry Stock Comparison

Sell
37

BRKL
Brookline Bancorp

Last Price:
8.43
Seasonality Move:
0.74%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.53
Seasonality Move:
4.22%
Sell
37
Brookline Bancorp (BRKL) is a Sell

Is Brookline Bancorp a Buy, Sell or Hold?

  • The current Brookline Bancorp [BRKL] share price is $8.23. The Score for BRKL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BRKL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRKL Stock Price Chart

What is Brookline Bancorp's stock price today?

  • The Brookline Bancorp share price today is $8.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRKL is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

BRKL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 41.95 Sell
Chaikin Money Flow: -220226 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.22 - 8.7) Sell
Bollinger Bands (100): (8.58 - 9.82) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

BRKL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.25 Sell
20-day SMA: 8.36 Sell
50-day SMA: 8.68 Sell
200-day SMA: 9.44 Sell
8-day EMA: 8.28 Sell
20-day EMA: 8.39 Sell
50-day EMA: 8.69 Sell
200-day EMA: 9.47 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

Brookline Bancorp Earnings Growth & BRKL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.22 per share, and an increase next year of $0.25 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Brookline Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):